Articles Archives - Page 16 of 746

ThursdaySep 11, 2025 9:45 am

AI Maverick Intel Inc. (BINP) Poised to Help Businesses Optimize the Customer Acquisition Experience Using AI

AI Maverick Intel is a tech company that provides AI-powered customer acquisition to optimize how businesses engage with leads and prospects It has the vision of eliminating friction from the process, and helping businesses replace heavy traditional outreach efforts with modern, streamlined, and automated engagement The company is led by CEO Wayne Cockburn, an experienced executive with over two decades of board experience across numerous businesses AI Maverick Intel (OTC: BINP) is a technology-forward organization that focuses on improving how companies acquire new customers. Traditional methods are time-consuming, resource-heavy, and intensive, and AI Maverick Intel uses AI and technology to…

ThursdaySep 11, 2025 9:00 am

Datavault AI Inc. (NASDAQ: DVLT) Is ‘One to Watch’

Datavault AI holds more than 70 issued and pending patents across AI, blockchain, tokenization, and acoustic science, including nine new patent allowances secured in 2025. The company is actively commercializing its stablecoin and tokenization technologies through new digital asset exchanges focused on carbon credits and political advertising. Its partnership network — including IBM WatsonX, NYIAX, Burke Products, Turner Global Media, and LifeGenix Institute — supports market access across defense, healthcare, digital media, and data licensing. The company’s patented audio platforms, including ADIO(R) and SyncIN(TM), enable secure ultrasonic transactions and mobile triggers across broadcast, retail, and streaming environments. With a vertically…

WednesdaySep 10, 2025 12:00 pm

HeartBeam Inc. (NASDAQ: BEAT) Advances Power of ECG with High-Fidelity At-Home Heart-Monitoring System

The system’s design emphasizes user friendliness and portability while aligning with the growing trend toward remote patient monitoring and telemedicine. HeartBeam to initiate commercial launch upon FDA clearance of 12-lead ECG synthesis software, anticipated later this year. For decades, the traditional 12-lead electrocardiogram (“ECG”) has been the gold standard in cardiac diagnostics, including arrhythmia assessment, offering a comprehensive assessment of the heart's electrical activity. However, traditional 12-lead ECG systems often come with limitations such as cumbersome setups and restricted accessibility. HeartBeam (NASDAQ: BEAT) is addressing these challenges by developing the HeartBeam System, the first cable-free, high-fidelity ECG system that captures the heart's…

WednesdaySep 10, 2025 11:15 am

GlobalTech Corporation (GLTK): Building Value Through AI, Big Data, and Digital Infrastructure

GlobalTech balances internal innovation with strategic acquisitions in AI, big data, and digital infrastructure Q2 2025 revenue increased 23.3% year-over-year to $5.63 million, driven by telecom services growth Company advancing capital markets profile with private placement and strategic advisor appointment, supporting uplisting ambitions Technology at the Core of Business Growth Technology has become the defining force behind business scalability, value, and social impact in the modern economy. As industries embrace the Fourth Industrial Revolution, platforms built on artificial intelligence (“AI”), big data, and digital infrastructure are reshaping global value chains. Companies that combine operational technology with access to capital markets…

WednesdaySep 10, 2025 10:30 am

OptimumBank Holdings Inc. (NYSE American: OPHC) Is ‘One to Watch’

OptimumBank has delivered record earnings and profitability, with 2024 net income of $13.1 million and Core ROAE above 23 percent, all achieved without credit losses for the past seven years. The company expects to surpass $1.2 billion in assets by the end of 2025 and projects continued growth to $1.5 to $1.6 billion by year-end 2026, supported by a clean balance sheet and no exposure to long-dated, low-yield bonds. OptimumBank achieved SBA Preferred Lender status in just over two years and grew its SBA lending program from zero, demonstrating rapid execution and small business demand. Strategic investments in a new…

WednesdaySep 10, 2025 9:45 am

Nutriband Inc. (NASDAQ: NTRB): When Market Confidence Validates Scientific Innovation

Recent warrant exercises at $6.43 generated $5.3 million, signaling investor conviction in AVERSA(TM) Fentanyl ahead of NDA filing AVERSA(TM) is a abuse-deterrent solution for transdermal patches, addressing a longstanding gap in pain management safety Strategic funding positions Nutriband to complete development and FDA submission, targeting $80–200 million in peak U.S. annual sales The pharmaceutical sector is defined by a critical balance between innovation and validation. Breakthroughs can take years of research, but they only achieve true market credibility when investors, partners, or acquirers signal confidence in commercial potential. For companies tackling complex problems like opioid abuse, that validation becomes especially…

WednesdaySep 10, 2025 9:00 am

Newton Golf Company Inc. (NASDAQ: NWTG) Integrates Advanced Technology to Elevate Golf Performance

Modern golfers rely on a range of innovations to enhance every aspect of their performance. Newton Golf Company has embraced the ideals of innovation and high tech, applying them directly to the design and production of its golf equipment. In addition to equipment, Newton Golf integrates technology into its customer experience, training and education services. Golf is evolving faster than ever, thanks to advancements in technology that are reshaping how players train, compete and enjoy the sport. Newton Golf Company (NASDAQ: NWTG) is at the forefront of this transformation, blending innovative technology with traditional craftsmanship to produce high-performance golf equipment.…

TuesdaySep 09, 2025 12:00 pm

OptimumBank Holdings Inc. (NYSE American: OPHC) Reports Higher Q2 Earnings as Deposits and Margins Expand

OptimumBank Holdings, Inc. posted Q2 2025 net earnings of $3.6 million, or $0.31 per basic share. Net interest margin rose to 4.32%, reflecting improved deposit pricing and asset yields. Total deposits increased by $25.93 million in the quarter, reaching $878.87 million. Noninterest income rose to $1.83 million, supported by loan sales and prepayment fees. Capital levels remain strong, with Tier 1 Capital to Total Assets at 11.89%. OptimumBank Holdings (NYSE American: OPHC), a single bank holding company that owns 100% of community bank OptimumBank, headquartered in Fort Lauderdale, Florida, reported higher earnings and positive financial results for the second quarter…

TuesdaySep 09, 2025 11:15 am

Vision Marine Technologies Inc. (NASDAQ: VMAR) Strengthens Electric Watercraft Position with Seabob Partnership

New partnership allows VMAR to “unite electric boats, toys and watersports equipment under one roof.” The new EV division at Nautical Ventures focuses on offering high-performance electric water toys, with the Seabob serving as its centerpiece. VMAR’s EV division’s collaboration with Nautical Ventures ensures that customers receive proper support, training and maintenance for their electric watercraft. The electric revolution is no longer confined to cars and trucks — it’s making waves in the boating world. As demand grows for sustainable, high-performance alternatives to gas-powered watercraft, Vision Marine Technologies (NASDAQ: VMAR) is stepping forward with a bold move. The company has…

TuesdaySep 09, 2025 10:30 am

Soligenix Inc. (NASDAQ: SNGX) Showcases Expanding Rare Disease, Public Health Pipeline in Latest Corporate Presentation

At its core, Soligenix is a late-stage biopharmaceutical company that thrives at the intersection of urgent medical need and scientific innovation. SNGX’s Specialized BioTherapeutics division is anchored by its proprietary HyBryte(TM) (“SGX301”), a novel photodynamic therapy for CTCL. Soligenix’s Public Health Solutions division positions the company as an important contributor to biodefense and emerging infectious disease. Soligenix (NASDAQ: SNGX) has taken a bold step forward with its latest corporate presentation, offering investors and the broader biotech community a deeper look into the company’s evolving strategy and pipeline (https://ibn.fm/YGu4N). The presentation underscores Soligenix’s dual focus: pioneering therapies for rare diseases that…

Site Search

Company Search

Category: Articles